Latest Healthcare Research Report

Researchmoz added Most up-to-date research on "Global Biosimilar Market Trends & Opportunities: 2015 Edition" to its huge collection of research reports. The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with increase in patent expiry of innovator drugs. The key market challenges recognized by the analysts and the major trends biosimilar market are presented in the report. Further, key manufacturers of Biosimilars like Sandoz, Teva, Hospira and Dr. Reddy’s Lab are profiled in the report. Product Coverage     Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)     Humira, Enbrel, Remicade, Herceptin     Recombinant Non-Glycosylated Biosimilars (Insulin,G-csf,Interferons,hGh)     Company Coverage     Sandoz(Novartis)     Hospira     Teva  ...

Researchmoz added Most up-to-date research on "Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016" to its huge collection of research reports. DelveInsight's, " Biosimilar (Insulin) - Competitive Landscape and Market & Pipeline Analysis, 2016" discusses the global insulin biosimilar industry. Report analyzes that Insulin and Insulin Biosimilars holds a future scope and potential in the market. It highlights the market trends, regulatory requirements for US and EU and key domestic players. Report provides an insight on Insulin Biosimilars that are under development for Type 1 and Type 2 Diabetes with an insight on the Epidemiology of the disease. It provides detailed information on the 11 Insulin Biosimilar that are in pipeline. It analyses Insulin Biosimilar industry and discusses the key market trends, major players, market assessment of 6 marketed insulin and the types of insulin with the length activity available in ma...